A detailed history of Vestcor Inc transactions in Viatris Inc stock. As of the latest transaction made, Vestcor Inc holds 19,535 shares of VTRS stock, worth $253,955. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,535
Previous 19,535 -0.0%
Holding current value
$253,955
Previous $208,000 9.13%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $97,733 - $117,332
-8,672 Reduced 30.74%
19,535 $233,000
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $2,631 - $3,255
-300 Reduced 1.05%
28,207 $305,000
Q2 2023

Aug 15, 2023

SELL
$9.02 - $10.29 $2,282 - $2,603
-253 Reduced 0.88%
28,507 $284,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $266,468 - $355,098
-28,964 Reduced 50.18%
28,760 $277,000
Q4 2022

Feb 15, 2023

SELL
$8.72 - $11.56 $1.23 Million - $1.63 Million
-140,955 Reduced 70.95%
57,724 $642,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $1.45 Million - $1.9 Million
170,533 Added 605.89%
198,679 $1.69 Million
Q2 2022

Aug 15, 2022

BUY
$9.95 - $12.27 $89,709 - $110,626
9,016 Added 47.13%
28,146 $295,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $280,369 - $440,132
-28,580 Reduced 59.9%
19,130 $208,000
Q4 2021

Feb 15, 2022

BUY
$12.09 - $14.68 $360,705 - $437,977
29,835 Added 166.91%
47,710 $646,000
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $36,901 - $42,137
-2,785 Reduced 13.48%
17,875 $242,000
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $23,346 - $29,069
-1,800 Reduced 8.01%
20,660 $295,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $240,189 - $327,675
-17,674 Reduced 44.04%
22,460 $314,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $573,916 - $752,111
40,134 New
40,134 $752,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Vestcor Inc Portfolio

Follow Vestcor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.